HomeEGTX • STO
add
Egetis Therapeutics AB (publ)
Previous close
kr 6.11
Day range
kr 6.01 - kr 6.19
Year range
kr 3.80 - kr 8.63
Market cap
1.79B SEK
Avg Volume
417.44K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
PTLO
7.67%
Financials
Income Statement
Revenue
Net income
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 12.10M | 77.94% |
Operating expense | 78.10M | 147.15% |
Net income | -75.00M | -0.13% |
Net profit margin | -619.83 | 43.73% |
Earnings per share | -0.30 | 0.00% |
EBITDA | -67.60M | 8.77% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 251.70M | 3.37% |
Total assets | 700.00M | 3.53% |
Total liabilities | 227.40M | 379.75% |
Total equity | 472.60M | — |
Shares outstanding | 292.57M | — |
Price to book | 3.77 | — |
Return on assets | -23.46% | — |
Return on capital | -27.43% | — |
Cash Flow
Net change in cash
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -75.00M | -0.13% |
Cash from operations | -55.40M | 30.31% |
Cash from investing | — | — |
Cash from financing | -600.00K | -100.31% |
Net change in cash | -51.60M | -144.60% |
Free cash flow | -33.68M | 34.94% |
About
Founded
2006
Website
Employees
28